Andrew Stewart Plump Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 1 hour ago
Andrew Stewart Plump has an estimated net worth of at least $22.1 million*, as of Sept. 2, 2026. They own 1.0 million shares of TAK stock. They have sold 301,235 shares of TAK stock since 2021, for an estimated $3.2 million.
Andrew Stewart Plump $TAK SEC Form 4 Insider Trading
Andrew Stewart Plump has filed a total of 3 insider trades in $TAK since 2021. Their most recent trade was a sale of 116,191 shares, made on Sep 02, 2026. Their largest trade was a sale of 165,393 shares, made on Aug 10, 2026. We estimate that they now own 1.0 million shares of $TAK, worth an estimated $18.9 million.
Insider Trading at $TAK
There have been a total of 19 insider trades reported at $TAK since 2021, with 0 shares purchased and 714,801 shares sold. The most active insider traders in $TAK stock have been Nicola Deidre Petal Greenway, Andrew Stewart Plump, and Elaine Mary Shannon. The most recent trade was a sale of 116,191 shares reported by Andrew Stewart Plump (President, R&D), made on Sep 02, 2026.
History of Insider Stock Trades by Andrew Stewart Plump
$TAK Executives and Stock Owners with Insider Trades
-
Nicola Deidre Petal Greenway, Chief Human Resources Officer
-
Andrew Stewart Plump, President, R&D
-
Elaine Mary Shannon, Pres., Global Supply & Quality
-
Agosti Marcello Pignagnoli, Head, Strat. & Port. Dev
-
Awny Samaan Botros Farajallah, Chief Medical Officer
-
Gabriele Ricci, Chief Data & Tech. Officer
-
Giles Richard Platford, President, IBU
-
Julie So-Young Kim, President and CEO
-
Lauren Rusckowski Duprey, Chief Transformation Officer
-
Natalie Anne Marie Furney, Global General Counsel
-
Ramy Riad Ahmed Ibrahim, President, PDT BU
-
Rhonda Janice Pacheco, President, U.S. Business Unit
-
Teresa Marie Bitetti, President, OBU
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.